McManus M E, Lang M A, Stuart K, Strong J
Biochem Pharmacol. 1982 Feb 15;31(4):547-52. doi: 10.1016/0006-2952(82)90158-7.
Rat liver microsomes and purified NADPH-cytochrome c reductase metabolized [14C]misonidazole anaerobically to a reactive intermediate that covalently binds to tissue macromolecules. Air strongly inhibited the binding whereas carbon monoxide had no effect, indicating that misonidazole is activated via reduction and not by cytochrome P-450-dependent oxidation. Both systems showed an absolute requirement for NADPH and were stimulated by flavine (FAD) and paraquat. The apparent Km for misonidazole binding to microsomal protein was 0.74 mM the apparent Vmax was 0.64 nmole 14C bound . mg-1 . min-1. At a single substrate concentration, nitrofurantoin, nitrofurazone and desmethylmisonidazole inhibited the covalent binding of misonidazole to microsomal protein by 47, 26, and 38% respectively. The effect of nitrofurantoin on the kinetics of misonidazole binding gave a complex interaction indicative of uncompetitive inhibition. Glutathione reduced the binding of misonidazole to microsomal protein below the level observed for boiled microsomes while ascorbic acid had no effect. Compared to nitrofurantoin and paraquat, misonidazole was a poor stimulator of superoxide production as measured by adrenochrome formation.
大鼠肝微粒体和纯化的NADPH-细胞色素c还原酶在厌氧条件下将[14C]米索硝唑代谢为一种活性中间体,该中间体与组织大分子共价结合。空气强烈抑制这种结合,而一氧化碳则无影响,这表明米索硝唑是通过还原而非细胞色素P-450依赖性氧化被激活的。两种体系都绝对需要NADPH,并受到黄素(FAD)和百草枯的刺激。米索硝唑与微粒体蛋白结合的表观Km为0.74 mM,表观Vmax为0.64 nmol 14C结合·mg-1·min-1。在单一底物浓度下,呋喃妥因、呋喃西林和去甲基米索硝唑分别抑制米索硝唑与微粒体蛋白的共价结合47%、26%和38%。呋喃妥因对米索硝唑结合动力学的影响呈现出复杂的相互作用,表明为非竞争性抑制。谷胱甘肽使米索硝唑与微粒体蛋白的结合低于煮沸微粒体所观察到的水平,而抗坏血酸则无作用。与呋喃妥因和百草枯相比,通过肾上腺素色素形成测定,米索硝唑对超氧化物产生的刺激作用较弱。